Tag: Francis Wheeler
Cooley, Davis Polk assist Chinese biopharma’s private placement
Cooley advises Gracell Biotechnologies, a Nasdaq-listed Chinese biopharmaceutical company, on its private placement financing of up to USD150 million
Cooley advises Gracell Biotechnologies, a Nasdaq-listed Chinese biopharmaceutical company, on its private placement financing of up to USD150 million
Japanese corporates have been actively turning to the overseas M&A market for expanding their business and enhancing capital efficiency